Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Reporter Account
Filter News
Show All Results
News By Country
News By Tag
Pharma Remove
Related Tags


February 2012
Fr Th We Tu Mo Su Sa
17 16 15 14 13 12 11

pharma News

  + XML/RSS  



By Frost & Sullivan
Participants shape research measuring perceptions and expectations for pharmaceutical drug delivery technologies

By CROS NT
CROS NT and ARITHMOS are sponsoring the ePharma Day series again in 2012. Only this year, the series has grown to include two new countries - Russia and the UK.

By CROS NT
The CRO market is projected to grow again in 2012 due to the pharmaceutical industry’s increased investment in outsourcing. When it comes to choosing a CRO, drugmakers want the niche vendors.

By Cambridge Healthtech Institute
Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

By Insight Pharma Reports
This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis.

By Carl Nagaitis
The Ellesmere Port - Based Independent Calibration and Maintenance Service Provider Marks Its 25th Anniversary By Expanding Into Scandinavia

By Cambridge Healthtech Institute
CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

By Insight Pharma Reports
New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD

By William Adler
Healthcare is in crisis throughout the world, but an innovative forum will seek solutions by connecting health, biotech and pharmaceutical CEOs and other senior executives with institutional investors and business development executives.

By American Conference Institute
Biotech patent circles are buzzing over the opportunity to engage USPTO patent examiners in an exclusive session at the American Conference Institute’s 13th Advanced Forum on Biotech Patents later this month in Boston.

By Carl Nagaitis
Andrew Miller Meets Technicians Of The Future At Britain's Largest Independent Calibration and Maintenance Company

By Insight Pharma Reports
New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

By mHealthcon
mHealth Alliance's leader,the group founded by UN Foundation will speak at mHealthcon Mobile Health Conference Dec.1st. Exclusively dedicated to the mobile health apps market, it will feature C-level speakers, exhibits workshops and product demos.

By Slokapr.com
The three-day India – Latin America and the Caribbean (LAC) Pharma Business Meet being organized by Pharmaceuticals Export Promotion Council (Pharmexcil) gets underway in the city from Tuesday, September 27, 2011.

By Insight Pharma Reports
View IPR’s Most Recent Report Titles from the 2011 Catalog and Our Newly Launched Insight Update Series.

By Lee Schwarz Black Lion Marketing
REMCON Plastics develops a custom designed hopper cradle assembly with the precision to work in an automated guided vehicle storage system

By Frost & Sullivan
Conference unites industry peers to strengthen forecasting strategies and improve performance in emerging markets

By SMi Group
This event will bring together senior scientists, medical directors, Biostatisticians to address and find solutions to current issues in biomarker efficiency and strategies

By Cambridge Healthtech Institute
Two thought-leaders and experts on phase II clinical trials will be the keynote speakers at the CHI’s Accelerating Proof of Concept: Clinical Success Driven by Science & Strategy, set for October 3-5 at the Crowne Plaza Hotel in Philadelphia, PA.

By Insight Pharma Reports
Insight Pharma Reports Announces Next-Generation Mass Spectrometry: Technology Advances and Applications, Authored by K. John Morrow, Jr., PhD.

All Press Releases

By Computer Courses
The "Process Improvement - The Global Trends" IT conference organized by Unicom Learning will take place in Bangalore, India on 12 Apr 2012.

By Bharatbook
Bharatbook.com added a new research report on "Partnering Yearbook 2012" which gives Comprehensive coverage of every deal announced in 2011.

By Joe Walsh
Piribo, the online destination for Pharma intelligence, has added a new report.

By Frost & Sullivan
Participants shape research measuring perceptions and expectations for pharmaceutical drug delivery technologies

By Michele Westergaard
Hear from the First Judicial Court, Philadelphia, Pfizer Inc., Bayer Healthcare and St. Jude Medical on Implementing Appropriate Litigation Readiness and Cost Management Policies

By SMi Group
With declining R&D costs, prioritizing a portfolio of successful projects has become essential within the pharmaceutical industry. Lifecycle management approaches must be implemented throughout a market period to ensure an increase in profit

By Pharma IQ
Industry wide economic climate study reveals bleak outlook for Pharmaceutical Industry in new report from Pharma-IQ.com

By SMi Group
This year’s Parallel Trade conference promises to present attendees with an in-depth overview and provide the prefect forum for debate and discussion

By TCG Lifesciences Limited
TCG Lifesciences Limited (TCGLS) announced the achievement of two distinct milestones in their ongoing drug discovery partnership with Endo Pharmaceuticals. TCGLS will receive undisclosed success fees against these milestones.

By CROS NT
CROS NT and ARITHMOS are sponsoring the ePharma Day series again in 2012. Only this year, the series has grown to include two new countries - Russia and the UK.

By Cambridge Healthtech Institute
A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx.

By CROS NT
The CRO market is projected to grow again in 2012 due to the pharmaceutical industry’s increased investment in outsourcing. When it comes to choosing a CRO, drugmakers want the niche vendors.

By Ajanta Pharma Limited
Mumbai – (January 24, 2012) – Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has posted 55% increase in net profit for the third quarter of FY 2011-12.

By IQPC
Kim Holt, Scientific manager for Chemistry at South West Water, joins IQPC Exchange to discuss the key learnings and tools from her experience at South West Water to achieve key business objectives through smarter and more efficient data management

By Cambridge Healthtech Institute
Dr. Leach will participate in a keynote session at this conference scheduled for Feb. 21-23, 2012, San Francisco, CA. The conference is organized by Cambridge Healthtech Institute.

By SMI Group
Join SMi at their 7th annual Pharmaceutical Portfolio & Lifecycle Management that will address the challenges associated with obtaining an optimal portfolio of projects.

By Cambridge Healthtech Institute
CHI’s Event Short Course is being held at the Molecular Med TRI-CON 2012 on February 20th at The Moscone North Convention Center in San Francisco.

By Insight Pharma Reports
This Insight Pharma Report focuses on the applications, technology and market aspects of high-content analysis.

By Carl Nagaitis
The Ellesmere Port - Based Independent Calibration and Maintenance Service Provider Marks Its 25th Anniversary By Expanding Into Scandinavia

By Cambridge Healthtech Institute
CHI’s Cancer Biologics conference is being held at the Molecular Med TRI-CON 2012 on February 21-23 at the Moscone in San Francisco.

By ARITHMOS
Working in conjunction with CROS NT pharmacovigilance services, ARITHMOS invests in technology integration to make pharmacovigilance data more readily available.

By IQPC
Werner Kexel, Managing Director, Eurocat and BSI, joins IQPC to discuss the 3rd revision to the standards guideline 60601 and tips for medical device manufacturers on how to prepare for the changes.

By IQPC
Kim Holt, Scientific manager for Chemistry at South West Water, joins IQPC Exchange to discuss the key learnings and tools from her experience at South West Water to achieve key business objectives

By Frost & Sullivan
The Food & Drug Administration is scheduled to release guidelines for the approval of biosimilars by the end of 2011

By Reimbursement Intelligence
Reimbursement Intelligence, a market-research firm helping biopharma, medical device and diagnostic firms succeed in managed markets, today announced how payers predict the impact of Pfizer’s radical strategy to stay in favor of consumers.

By IQPC
In the last few years there has been a huge leap in the amount of intuitive and interactive technology available to individuals and organisations in order to make their lives easier. Increasingly, laboratories are leaving paper-based data management

By IQPC
As technology advances, software design plays an increasingly critical role in a growing number of healthcare divisions. In the global medical device industry, little has had the same level of impact on the design of software for medical devices

By IQPC
Enormous technological leaps have changed almost every aspect of the modern lives we lead and how our jobs are done.

By SMi Group
With declining R&D costs, prioritizing a portfolio of successful projects has become essential within the pharmaceutical industry.

By Insight Pharma Reports
New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD

By William Adler
Healthcare is in crisis throughout the world, but an innovative forum will seek solutions by connecting health, biotech and pharmaceutical CEOs and other senior executives with institutional investors and business development executives.

By Webchutney
Webchutney announces launch of its digital healthcare report in India.

By Reportsnreports
Globaldata’s” M&A Activity In The Unconventional Oil & Gas Segment - Q3 2011 ” is now available at ReportsnReports.com.

By Frost & Sullivan
Pharmacists perceive themselves as having a strong say in patients’ purchase decisions

By American Conference Institute
Biotech patent circles are buzzing over the opportunity to engage USPTO patent examiners in an exclusive session at the American Conference Institute’s 13th Advanced Forum on Biotech Patents later this month in Boston.

By Visiongain
Visiongain predicts that the antibody therapeutics sector will be revitalised by the approval of next-generation products this decade. Overall next-generation therapeutic antibody revenues will reach $2.3bn in 2015.

By Carl Nagaitis
Andrew Miller Meets Technicians Of The Future At Britain's Largest Independent Calibration and Maintenance Company

By Only Medics
Bart Bierman M.D, who has 25+ Years experience within the pharmaceutical industry discusses what is required to be a successful interim.

By Visiongain
Visiongain predicts that small-molecule targeted cancer therapy revenues will reach $27.3bn worldwide in 2015. That overall market generated $20.3bn in 2010, according to Small-Molecule Targeted Cancer Therapies: World Market 2011-2021.

By Frost & Sullivan
Cost and productivity benefits ensure greater traction for CRO services

By Insight Pharma Reports
New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

By IQPC
Eric Ruhlmann, European Patent Attorney Director, Senior Patent Counsel, Legal Department, Actelion Pharmaceuticals Ltd, joins Pharma IQ, to discuss the latest challenges for patenting pharmaceutical inventions and trends in global patent law

By IQPC
Enormous technological leaps have changed almost every aspect of the modern lives we lead and how our jobs are done.

By IQPC
The pharmaceutical industry's 'cold chain', the controlled route along which temperature-sensitive products are distributed, plays a critical role in ensuring the shelf life and integrity of medicines and biologics.

By Ajanta Pharma Limited
Mumbai – (October 24, 2011) – Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has posted 18% increase in net profit for the second quarter of FY 2011-12.

By mHealthcon
mHealth Alliance's leader,the group founded by UN Foundation will speak at mHealthcon Mobile Health Conference Dec.1st. Exclusively dedicated to the mobile health apps market, it will feature C-level speakers, exhibits workshops and product demos.

By Visiongain
20 October 2011. London. UK. A new report by visiongain, a London-based business information company, predicts that world revenues for epigenetic therapies and technologies will reach $2.73bn in 2015.

By SMi Group
Hear directly from GSK and other pharmaceutical companies on how they are developing their social media strategy at...

By IQPC
As technology advances, software design plays an increasingly critical role in a growing number of healthcare divisions.

By Insight Pharma Reports
Just Published Report on Cytokine-Based Therapies and Inhibitors: R&D Pipelines, Markets, and Strategic Issues



Page:



  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
2.8K1.1K1.1K
Click to Share